In March 2025, the company announced new plans for the direct-to-client giving of its Wegovy weight loss drug. The company set up a completely new pharmacy, termed NovoCare, which might demand shoppers $499 every month for usage of the drug, fewer than 50 percent the expense of the drug through other pharmaceutical distribution networks.[fifty thre